Received Mar 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | — | LA |
| RSV | RSV (ABRYSVO) | PFIZER\WYETH | 1 | mn0308 | LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | LA |
Muscle pain; severe headache; chills; hearing sensitivity; chest discomfort; nausea; not able to concentrate; pain in injection site; unable to move arm; This is a spontaneous report received from an Other HCP. A 57-year-old female patient (not pregnant) received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 19Mar2026 as dose 1, single (Lot number: mn0308) at the age of 57 years, in left deltoid for immunisation; pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 19Mar2026 as dose 1, single (Batch/Lot number: unknown) at the age of 57 years, in left arm for immunisation; diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (BOOSTRIX), on 19Mar2026 as dose 1, in left arm. The patient's relevant medical history included: "Latex allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: MYALGIA (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering", described as "Muscle pain"; CHEST DISCOMFORT (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering"; CHILLS (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering"; HYPERACUSIS (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering", described as "hearing sensitivity"; NAUSEA (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering"; DISTURBANCE IN ATTENTION (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering", described as "not able to concentrate"; VACCINATION SITE PAIN (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering", described as "pain in injection site"; HEADACHE (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering", described as "severe headache"; MOVEMENT DISORDER (non-serious) with onset 19Mar2026 at 19:30, outcome "recovering", described as "unable to move arm". Therapeutic measures were not taken as a result of myalgia, headache, chills, hyperacusis, chest discomfort, nausea, disturbance in attention, vaccination site pain, movement disorder. Additional information: The patient did not received any other vaccines within 4 weeks prior to the vaccine, not taking any other medications within 2 weeks of the event starting. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Latex allergy